Search

everythinglearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Potential therapeutic targets for scarring hair loss are identified.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Thermo-responsive polymers in nanoparticles enable targeted drug delivery and advanced therapies by releasing drugs at specific temperatures.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Optimized liposomes can improve drug delivery and effectiveness.

Nanoemulsions improve drug delivery and skincare effectiveness.

A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Peptide hydrogels are promising for drug delivery and tissue repair in medicine.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

The hydrogel improves hair growth treatment by enhancing drug delivery and promoting follicle repair.

Both new medications and non-drug treatments can effectively manage migraines with fewer side effects.

AI is transforming healthcare by improving diagnostics and therapy, despite challenges with data and trust.